P213 Lasiodiplodia theobromae: an emerging human pathogen

IF 1.4 Q4 MYCOLOGY
R. Kanaujia, Sunita Gupta, H. Kaur, A. Kindo, A. Shetty, R. Marak, R. Rammohan, N. Singla, M. Capoor, G. Balajee, L. Gopal, V. Rastogi, T. Karuna, B. Hemashettar, Sheetal Harkuni, S. M
{"title":"P213 Lasiodiplodia theobromae: an emerging human pathogen","authors":"R. Kanaujia, Sunita Gupta, H. Kaur, A. Kindo, A. Shetty, R. Marak, R. Rammohan, N. Singla, M. Capoor, G. Balajee, L. Gopal, V. Rastogi, T. Karuna, B. Hemashettar, Sheetal Harkuni, S. M","doi":"10.1093/mmy/myac072.P213","DOIUrl":null,"url":null,"abstract":"Abstract Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Objectives Lasiodiplodia theobromae is a dematiaceous fungus, rarely reported to cause infections in humans. This case-series was conducted to identify the potential risk-factors and spectrum of diseases caused by L. theobromae. Methods We performed a retrospective analysis of all cases from which the isolates of the L. theobromae were accessioned at the National culture collection of pathogenic fungi (NCCPF), over the last 10 years (January 2012- March 2022). The isolates were retrieved and identified by conventional (colony morphology, color, and microscopic appearances) and molecular (sequencing of ITS1 region of ribosomal DNA) methods. In vitro antifungal susceptibility testing (AFST) was performed by microbroth dilution recommended by the Clinical and Laboratory Standards Institute (CLSI). (M38-A2). The clinical features, demographic details and outcome were recorded. Results In 10 years, a total of 20 patients were identified. The median age of all cases was 39.5 (range: 13-71 years) and 75% were males. The most common clinical presentation was keratomycosis (12,68.6%), followed by soft tissue/sub-cutaneous infection (3,15%), rhinosinusitis (3,15%), onychomycosis (1, 5%), and pneumonia (1, 5%). Most patients were immunocompetent (85%). Among immunocompromised, two patients had acute myeloid leukemia and developed fungal rhinosinusitis while one patient of post-renal transplant on immunosuppressants developed subcutaneous tissue infection in the interscapular region. The fourth patient had decompensated alcoholic hepatitis, encephalopathy, sepsis, and developed pneumonia while he was on mechanical ventilation. Among the various potential risk factors associated with keratomycosis, the most common were, accidental trauma wounds (9, 45%), and mosquito bite in the eye in one patient. The culture on Sabouraud's dextrose agar (SDA) revealed the growth of black mycelial fungus (Fig. 1a). The lactophenol cotton blue (LCB) mount revealed the presence of only dematiaceous septate hyphae which failed to sporulate (Fig. 1b). All the isolates were confirmed by sequencing of ITS (internal transcribed spacer) region of the rDNA using universal primers ITS1 and ITS2. In vitro antifungal susceptibility testing (AFST) was performed using a broth microdilution (BMD) method which revealed variable MIC (μg/ml), i.e., amphotericin (1-2), voriconazole (0.25-2), itraconazole (8-16), posaconazole (1-2). All patients improved on therapy except one patient who succumbed to death due to pneumonia. Conclusion Lasiodiplodia theobromae is an emerging cause of human infections in both immunocompetent and immunosuppressed individuals. It is often difficult to identify due to lack of sporulation making morphological identification challenging. Hence, prompt suspicion and rapid diagnosis with guided therapy are necessary for a better outcome.","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"16 1","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/mmy/myac072.P213","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Abstract Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Objectives Lasiodiplodia theobromae is a dematiaceous fungus, rarely reported to cause infections in humans. This case-series was conducted to identify the potential risk-factors and spectrum of diseases caused by L. theobromae. Methods We performed a retrospective analysis of all cases from which the isolates of the L. theobromae were accessioned at the National culture collection of pathogenic fungi (NCCPF), over the last 10 years (January 2012- March 2022). The isolates were retrieved and identified by conventional (colony morphology, color, and microscopic appearances) and molecular (sequencing of ITS1 region of ribosomal DNA) methods. In vitro antifungal susceptibility testing (AFST) was performed by microbroth dilution recommended by the Clinical and Laboratory Standards Institute (CLSI). (M38-A2). The clinical features, demographic details and outcome were recorded. Results In 10 years, a total of 20 patients were identified. The median age of all cases was 39.5 (range: 13-71 years) and 75% were males. The most common clinical presentation was keratomycosis (12,68.6%), followed by soft tissue/sub-cutaneous infection (3,15%), rhinosinusitis (3,15%), onychomycosis (1, 5%), and pneumonia (1, 5%). Most patients were immunocompetent (85%). Among immunocompromised, two patients had acute myeloid leukemia and developed fungal rhinosinusitis while one patient of post-renal transplant on immunosuppressants developed subcutaneous tissue infection in the interscapular region. The fourth patient had decompensated alcoholic hepatitis, encephalopathy, sepsis, and developed pneumonia while he was on mechanical ventilation. Among the various potential risk factors associated with keratomycosis, the most common were, accidental trauma wounds (9, 45%), and mosquito bite in the eye in one patient. The culture on Sabouraud's dextrose agar (SDA) revealed the growth of black mycelial fungus (Fig. 1a). The lactophenol cotton blue (LCB) mount revealed the presence of only dematiaceous septate hyphae which failed to sporulate (Fig. 1b). All the isolates were confirmed by sequencing of ITS (internal transcribed spacer) region of the rDNA using universal primers ITS1 and ITS2. In vitro antifungal susceptibility testing (AFST) was performed using a broth microdilution (BMD) method which revealed variable MIC (μg/ml), i.e., amphotericin (1-2), voriconazole (0.25-2), itraconazole (8-16), posaconazole (1-2). All patients improved on therapy except one patient who succumbed to death due to pneumonia. Conclusion Lasiodiplodia theobromae is an emerging cause of human infections in both immunocompetent and immunosuppressed individuals. It is often difficult to identify due to lack of sporulation making morphological identification challenging. Hence, prompt suspicion and rapid diagnosis with guided therapy are necessary for a better outcome.
可可线虫:一种新出现的人类病原体
摘要:海报会议2,2022年9月22日,12:30 PM - 1:30 PM目的可可叶枯病(Lasiodiplodia theobromae)是一种真菌,很少报道引起人类感染。本病例系列的目的是确定可可乳杆菌引起的潜在危险因素和疾病谱。方法回顾性分析近10年来(2012年1月- 2022年3月)在国家病原真菌培养收集(NCCPF)中获得的所有分离株的病例。通过常规方法(菌落形态、颜色和显微外观)和分子方法(核糖体DNA ITS1区测序)对分离株进行检索和鉴定。体外抗真菌药敏试验(AFST)采用临床与实验室标准协会(CLSI)推荐的微肉汤稀释法进行。(M38-A2)。记录临床特征、人口学细节和结果。结果10年内共确诊患者20例。所有病例的中位年龄为39.5岁(范围:13-71岁),75%为男性。最常见的临床表现是角肿病(12.68.6%),其次是软组织/皮下感染(3.15%)、鼻窦炎(3.15%)、甲癣(1.5%)和肺炎(1.5%)。大多数患者具有免疫能力(85%)。免疫功能低下患者中,2例发生急性髓性白血病并发真菌性鼻窦炎,1例接受免疫抑制剂的肾移植术后并发肩胛间区皮下组织感染。第4例患者在机械通气期间出现失代偿性酒精性肝炎、脑病、败血症和肺炎。在与角膜真菌病相关的各种潜在危险因素中,最常见的是意外创伤(9.45%)和蚊虫叮咬(1例)。在Sabouraud’s葡萄糖琼脂(SDA)上进行培养,发现黑色菌丝体真菌生长(图1a)。在乳酚棉蓝(LCB)培养基上发现,只有乳脂质分离菌丝不能产孢(图1b)。所有分离株均采用通用引物ITS1和ITS2对rDNA的ITS (internal transcriptionspacer)区进行测序。采用微量肉汤稀释法(BMD)进行体外抗真菌药敏试验(AFST), MIC值(μg/ml)为:两性霉素(1-2)、伏立康唑(0.25-2)、伊曲康唑(8-16)、泊沙康唑(1-2)。除一名患者因肺炎死亡外,所有患者经治疗均有所改善。结论可可裂瓣虫在免疫正常和免疫抑制人群中都是一种新的感染原因。由于缺乏孢子使形态学鉴定具有挑战性,通常难以识别。因此,及时怀疑和快速诊断与指导治疗是必要的,以获得更好的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical mycology journal
Medical mycology journal Medicine-Infectious Diseases
CiteScore
1.80
自引率
10.00%
发文量
16
期刊介绍: The Medical Mycology Journal is published by and is the official organ of the Japanese Society for Medical Mycology. The Journal publishes original papers, reviews, and brief reports on topics related to medical and veterinary mycology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信